← All organizations
Highest phase reached
Phase 2
First clinical trial
Dec 1, 2020Last known activity
Dec 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 9 trials)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
Recent trials (17)
- NCT06728982OfficialPhase 1/Phase 2Dec 31, 2024
- NCT06525363Lead sponsorPhase 1Aug 1, 2024
- NCT06525363Sponsor investigatorPhase 1Aug 1, 2024
- NCT06060691Lead sponsorPhase 1Sep 20, 2023
- NCT05592041Reponsible party - principal investigatorEarly Phase 1Oct 20, 2022
- NCT05592041Lead sponsorEarly Phase 1Oct 20, 2022
- NCT06070571OfficialPhase 1May 20, 2022
- NCT06070571Lead sponsorPhase 1May 20, 2022
- NCT05328414Reponsible party - principal investigatorPhase 1/Phase 2Mar 1, 2022
- NCT05328414Lead sponsorPhase 1/Phase 2Mar 1, 2022
- NCT05142072Lead sponsorEarly Phase 1Dec 18, 2021
- NCT05142072Reponsible party - principal investigatorEarly Phase 1Dec 18, 2021
- NCT04768829Reponsible party - principal investigatorEarly Phase 1Feb 18, 2021
- NCT04768829Overall official - principal investigatorEarly Phase 1Feb 18, 2021
- NCT04768829Lead sponsorEarly Phase 1Feb 18, 2021
Details
- Last known activity
- Dec 31, 2024